Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Rituximab
MabThera
Routinely available
SMC (330/06)
01/05/2007
Indication
Relapsed/refractory follicular lymphoma
Therapeutic Area
Malignant disease and immunosuppression
Status Description
Routinely available
Formulation
10mg/ml concentrate for infusion
Comments
May 2007 - Added to the Additional List, for Specialist Use only.